siRNA against TSG101 reduces proliferation and induces G0/G1 arrest in renal cell carcinoma – involvement of c-myc, cyclin E1, and CDK2

被引:0
作者
Chen Xu
Junhua Zheng
机构
[1] Tenth People’s Hospital of Tongji University,Department of Urology
来源
Cellular & Molecular Biology Letters | 2019年 / 24卷
关键词
Renal cell carcinoma; TSG101; Cell proliferation; Cell cycle;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 160 条
[1]  
Siegel RL(2017)Cancer statistics, 2017 CA Cancer J Clin 67 7-30
[2]  
Miller KD(2016)Renal cancer Lancet 387 894-906
[3]  
Jemal A(2005)New treatments for metastatic kidney cancer Can J Urol 12 66-70
[4]  
Capitanio U(2016)Improvement in survival end points of patients with metastatic renal cell carcinoma through sequential targeted therapy Cancer Treat Rev 50 109-117
[5]  
Montorsi F(2006)Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma J Clin Oncol 24 16-24
[6]  
Mancuso A(2009)Resistance to targeted therapy in renal-cell carcinoma Lancet Oncol 10 992-1000
[7]  
Sternberg CN(1997)The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer Cell 88 143-154
[8]  
Calvo E(2009)Hybrid structural model of the complete human ESCRT-0 complex Structure 17 406-416
[9]  
Schmidinger M(2008)Midbody targeting of the ESCRT machinery by a noncanonical coiled coil in CEP55 Science 322 576-580
[10]  
Heng DY(2004)Physical and functional interactions between Daxx and TSG101 Biochem Biophys Res Commun 316 827-833